Hyponatremia in the neurocritical care patient: An approach based on current evidence.
| Autor: | Manzanares W; Cátedra de Medicina Intensiva, Centro de Tratamiento Intensivo, Hospital de Clínicas, Facultad de Medicina, Universidad de la República (UdeLaR), Montevideo, Uruguay. Electronic address: wmanzanares@adinet.com.uy., Aramendi I; Cátedra de Medicina Intensiva, Centro de Tratamiento Intensivo, Hospital de Clínicas, Facultad de Medicina, Universidad de la República (UdeLaR), Montevideo, Uruguay., Langlois PL; Hôpital Fleurimont, Centre Hospitalier Universitaire de Sherbrooke, Département d'Anesthésie-Réanimation, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Québec, Canadá, Biestro A; Cátedra de Medicina Intensiva, Centro de Tratamiento Intensivo, Hospital de Clínicas, Facultad de Medicina, Universidad de la República (UdeLaR), Montevideo, Uruguay. |
|---|---|
| Jazyk: | English; Spanish; Castilian |
| Zdroj: | Medicina intensiva [Med Intensiva] 2015 May; Vol. 39 (4), pp. 234-43. Date of Electronic Publication: 2015 Jan 13. |
| DOI: | 10.1016/j.medin.2014.11.004 |
| Abstrakt: | In the neurocritical care setting, hyponatremia is the commonest electrolyte disorder, which is associated with significant morbimortality. Cerebral salt wasting and syndrome of inappropriate antidiuretic hormone have been classically described as the 2 most frequent entities responsible of hyponatremia in neurocritical care patients. Nevertheless, to distinguish between both syndromes is usually difficult and useless as volume status is difficult to be determined, underlying pathophysiological mechanisms are still not fully understood, fluid restriction is usually contraindicated in these patients, and the first option in the therapeutic strategy is always the same: 3% hypertonic saline solution. Therefore, we definitively agree with the current concept of "cerebral salt wasting", which means that whatever is the etiology of hyponatremia, initially in neurocritical care patients the treatment will be the same: hypertonic saline solution. (Copyright © 2014 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|